Birchview Capital, LP Aspira Women'S Health Inc. Transaction History

Birchview Capital, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	SELL	$0.38 - $1.07 $8,752 - $24,646	-23,034 Reduced 27.72%	60,070 $22,000
Q2 2022 Aug 12, 2022	SELL	$0.4 - $1.09 $8,000 - $21,800	-20,000 Reduced 19.4%	83,104 $49,000
Q1 2021 May 14, 2021	SELL	$5.9 - $9.13 $4.35 Million - $6.73 Million	-737,000 Reduced 87.73%	103,104 $696,000
Q4 2020 Feb 09, 2021	SELL	$3.0 - $6.71 $6.75 Million - $15.1 Million	-2,250,000 Reduced 72.81%	840,104 $5.62 Million
Q3 2020 Nov 12, 2020	SELL	$2.54 - $4.56 $526,143 - $944,572	-207,143 Reduced 6.28%	3,090,104 $9.51 Million
Q2 2020 Aug 10, 2020	BUY	$0.78 - $5.25 $2.57 Million - $17.3 Million	3,297,247 New	3,297,247 $12.7 Million

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $123M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of Birchview Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Birchview Capital, LP with notifications on news.